RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/26379425http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/26379425http://www.w3.org/2000/01/rdf-schema#comment"The objective of this study was to investigate the anticancer efficacy of dimercaptosuccinic acid-modified iron oxide magnetic nanoparticles coloaded with anti-CD22 antibodies and doxorubicin (anti-CD22-MNPs-DOX) on non-Hodgkin's lymphoma cells. The physical properties of anti-CD22-MNPs-DOX were studied and its antitumor effect on Raji cells in vitro was evaluated using the Cell Counting Kit-8 assay. Furthermore, cell apoptosis and intracellular accumulation of doxorubicin were determined by flow cytometry. The results revealed that anti-CD22-MNPs-DOX inhibited the proliferation of Raji cells, significantly increased the uptake of doxorubicin, and induced apoptosis. Therefore, it was concluded that a coloaded antibody and chemotherapeutic drug with magnetic nanoparticles might be an efficient targeted treatment strategy for non-Hodgkin's lymphoma."xsd:string
http://purl.uniprot.org/citations/26379425http://purl.org/dc/terms/identifier"doi:10.2147/dddt.s86764"xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/author"Fang Y."xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/author"Lu Q."xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/author"Zhang Y."xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/author"Wang J."xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/author"Song L."xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/author"Sun M."xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/author"Xia G."xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/date"2015"xsd:gYear
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/name"Drug Des Devel Ther"xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/pages"5123-5133"xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/title"Novel synthesizing method of pH-dependent doxorubicin-loaded anti-CD22-labelled drug delivery nanosystem."xsd:string
http://purl.uniprot.org/citations/26379425http://purl.uniprot.org/core/volume"9"xsd:string
http://purl.uniprot.org/citations/26379425http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/26379425
http://purl.uniprot.org/citations/26379425http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/26379425
http://purl.uniprot.org/uniprot/#_B7Z6Y6-mappedCitation-26379425http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26379425
http://purl.uniprot.org/uniprot/#_Q0EAF5-mappedCitation-26379425http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26379425
http://purl.uniprot.org/uniprot/#_O95700-mappedCitation-26379425http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26379425
http://purl.uniprot.org/uniprot/#_P20273-mappedCitation-26379425http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26379425
http://purl.uniprot.org/uniprot/#_O60926-mappedCitation-26379425http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26379425
http://purl.uniprot.org/uniprot/#_Q9H5X8-mappedCitation-26379425http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26379425
http://purl.uniprot.org/uniprot/#_Q9UQB1-mappedCitation-26379425http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26379425
http://purl.uniprot.org/uniprot/#_Q9UQB2-mappedCitation-26379425http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26379425